Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypersensitivity Reaction

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 105 articles:
HTML format
Text format



Single Articles


    April 2017
  1. CHEOK S, Yee F, Ma JYS, Leow R, et al
    Prevalence and Descriptive Epidemiology of Atopic Dermatitis and Its Impact on Quality of Life in Singapore.
    Br J Dermatol. 2017 Apr 17. doi: 10.1111/bjd.15587.
    PubMed     Text format     Abstract available


  2. CHANSKY PB, Mittal L, Werth VP
    Dermatological evaluation in patients with skin of colour: the effect of erythema on outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:853-854.
    PubMed     Text format    


  3. NALDI L
    Finding a HOME for outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:852-853.
    PubMed     Text format    


  4. WHITE IR
    Quantitative risk assessment and the burden of fragrance contact allergy.
    Br J Dermatol. 2017;176:860-861.
    PubMed     Text format    


    March 2017
  5. SAEKI H, Kabashima K, Tokura Y, Murata Y, et al
    Efficacy and Safety of Ustekinumab in Japanese Patients with Severe Atopic Dermatitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study.
    Br J Dermatol. 2017 Mar 24. doi: 10.1111/bjd.15493.
    PubMed     Text format     Abstract available


  6. ANDERSEN YM, Egeberg A, Gislason GH, Skov L, et al
    Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis.
    Br J Dermatol. 2017 Mar 23. doi: 10.1111/bjd.15489.
    PubMed     Text format     Abstract available


  7. RAMZY AG, Lammintausta K, Matura M, B Christensson J, et al
    Isothiocyanates are important as haptens in contact allergy to chloroprene rubber.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15444.
    PubMed     Text format     Abstract available


    February 2017
  8. LI S, Villarreal M, Stewart S, Choi J, et al
    Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 28. doi: 10.1111/bjd.15409.
    PubMed     Text format     Abstract available


  9. ERIKSSON S, van der Plas MJ, Morgelin M, Sonesson A, et al
    Antibacterial and anti-biofilm effects of sodium hypochlorite against Staphylococcus aureus isolates derived from patients with atopic dermatitis.
    Br J Dermatol. 2017 Feb 26. doi: 10.1111/bjd.15410.
    PubMed     Text format     Abstract available


  10. CHANG J, Bilker WB, Hoffstad O, Margolis DJ, et al
    Cross-Sectional Comparisons of Patient-Reported Disease Control, Disease Severity, and Symptom Frequency in Children with Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 24. doi: 10.1111/bjd.15403.
    PubMed     Text format     Abstract available


  11. DYBBOE R, Bandier J, Skov L, Engstrand L, et al
    The Role of the Skin Microbiome in Atopic Dermatitis: A Systematic Review.
    Br J Dermatol. 2017 Feb 16. doi: 10.1111/bjd.15390.
    PubMed     Text format     Abstract available


  12. PEETERS C, Herman A, Baeck M
    Donkey's milk allergy.
    Br J Dermatol. 2017 Feb 11. doi: 10.1111/bjd.15367.
    PubMed     Text format     Abstract available


  13. LINDBERG M, Soderquist B
    Atopic dermatitis and gut microbiota.
    Br J Dermatol. 2017;176:297-298.
    PubMed     Text format    


    January 2017
  14. MUGHAL AA
    What substances are allergenic and in whom?
    Br J Dermatol. 2017;176:14-15.
    PubMed     Text format    


    December 2016
  15. ZHAO CY, Hao EY, Oh DD, Daniel BS, et al
    A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate to dark skin patients.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15271.
    PubMed     Text format     Abstract available


  16. BENSEFA-COLAS L, Stocks SJ, McNamee R, Faye S, et al
    Effectiveness of the European Chromium VI Directive for cement implementation on occupational allergic contact dermatitis occurrence: Assessment in France and UK.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15261.
    PubMed     Text format     Abstract available


  17. NIC DHONNCHA E, Clowry J, Dunphy M, Buckley C, et al
    Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15262.
    PubMed     Text format     Abstract available


    November 2016
  18. ROEKEVISCH E, Leeflang MM, Schram ME, Campbell LE, et al
    Atopic dermatitis patients with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
    Br J Dermatol. 2016 Nov 19. doi: 10.1111/bjd.15191.
    PubMed     Text format     Abstract available


  19. BENNIKE NH, Zachariae C, Duus Johansen J
    Trends in contact allergy to fragrance mix I in consecutive Danish eczema patients over three decades; a cross-sectional study from 1986 to 2015.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15180.
    PubMed     Text format     Abstract available


  20. GONZALEZ-LOPEZ G, Ceballos-Rodriguez RM, Gonzalez-Lopez JJ, Feito Rodriguez M, et al
    Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2016 Nov 8. doi: 10.1111/bjd.15165.
    PubMed     Text format     Abstract available


  21. KOPPES SA, Ljubojevic Hadzavdic S, Jakasa I, Franceschi N, et al
    Stratum corneum profiles of inflammatory mediators in patch test reactions to common contact allergens and sodium lauryl sulfate.
    Br J Dermatol. 2016 Nov 4. doi: 10.1111/bjd.15163.
    PubMed     Text format     Abstract available


  22. DAMSKY W, King BA
    STATing the obvious: it's time for new treatments in atopic dermatitis.
    Br J Dermatol. 2016;175:861-862.
    PubMed     Text format    


  23. EDWARDS C
    Measurements of structure and function of skin: emollient effects on atopic dermatitis.
    Br J Dermatol. 2016;175:868-869.
    PubMed     Text format    


  24. STROM MA, Fishbein AB, Paller AS, Silverberg JI, et al
    Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.
    Br J Dermatol. 2016;175:920-929.
    PubMed     Text format     Abstract available


  25. TAKEHARA A, Aoyama Y, Kurosawa M, Shirafuji Y, et al
    Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2016;175:944-952.
    PubMed     Text format     Abstract available


    October 2016
  26. HEPBURN L, Hijnen DJ, Sellman BR, Mustelin T, et al
    The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.
    Br J Dermatol. 2016 Oct 25. doi: 10.1111/bjd.15139.
    PubMed     Text format     Abstract available


    September 2016
  27. HALLING-OVERGAARD AS, Kezic S, Jakasa I, Engebretsen KA, et al
    Skin absorption through atopic dermatitis skin: a systematic review.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15065.
    PubMed     Text format     Abstract available


  28. ORCIANI M, Campanati A, Caffarini M, Ganzetti G, et al
    Th1 -Th17 and Th2 imbalance in Mesenchymal Stem Cells of adult patients with atopic dermatitis: at the origin of the problem.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15078.
    PubMed     Text format     Abstract available


    August 2016
  29. VENABLES ZC, Bourke JF, Buckley DA, Campbell F, et al
    Has the epidemic of allergic contact dermatitis due to Methylisothiazolinone reached its peak?
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15016.
    PubMed     Text format     Abstract available


  30. LEE UH, Kim BE, Kim DJ, Cho YG, et al
    Atopic dermatitis is associated with reduced corneodesmosin expression: role of cytokine modulation and effects on viral penetration.
    Br J Dermatol. 2016 Aug 30. doi: 10.1111/bjd.15010.
    PubMed     Text format     Abstract available


  31. MOSE KF, Andersen F, Skov L, Ropke MA, et al
    Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14949.
    PubMed     Text format     Abstract available


  32. KIM J, Han Y, Ahn JH, Kim SW, et al
    Airborne formaldehyde causes skin barrier dysfunction in atopic dermatitis.
    Br J Dermatol. 2016;175:357-63.
    PubMed     Text format     Abstract available


    July 2016
  33. BISSONNETTE R, Papp KA, Poulin Y, Gooderham M, et al
    Topical tofacitinib for atopic dermatitis: A Phase 2a randomised trial.
    Br J Dermatol. 2016 Jul 16. doi: 10.1111/bjd.14871.
    PubMed     Text format     Abstract available


    June 2016
  34. LYNCH MD, White JM, McFadden JP, Wang Y, et al
    A dynamic landscape of allergen associations in delayed-type cutaneous hypersensitivity.
    Br J Dermatol. 2016 Jun 10. doi: 10.1111/bjd.14793.
    PubMed     Text format     Abstract available


    May 2016
  35. PONGPAIROJ K, McFadden JP, Basketter DA
    Advice for patients with hair dye allergy remains 'stop using permanent hair dyes'.
    Br J Dermatol. 2016;174:957-8.
    PubMed     Text format    


  36. LAPI F, Cassano N, Pegoraro V, Cataldo N, et al
    Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy.
    Br J Dermatol. 2016;174:996-1004.
    PubMed     Text format     Abstract available


  37. ZIMMER S, Peveling-Oberhag A, Weber A, Gilfert T, et al
    Unique coexistence of cold and solar urticaria and its efficient treatment.
    Br J Dermatol. 2016;174:1150-2.
    PubMed     Text format    


  38. HAWKEY S, Abdul Ghaffar S
    Glove-related hand urticaria: an increasing occupational problem among healthcare workers.
    Br J Dermatol. 2016;174:1137-40.
    PubMed     Text format    


    April 2016
  39. STROM MA, Silverberg JI
    Association between atopic dermatitis and extracutaneous infections in US adults.
    Br J Dermatol. 2016 Apr 28. doi: 10.1111/bjd.14708.
    PubMed     Text format     Abstract available


  40. MEDING B, Jarvholm B
    Comments on "Prevalence of contact allergy in the general population in different European regions" and "Prevalence of fragrance contact allergy in the general population of five European countries".
    Br J Dermatol. 2016 Apr 5. doi: 10.1111/bjd.14641.
    PubMed     Text format     Abstract available


  41. SAWATKAR GU, Sahu KK, Prakash G, Dogra S, et al
    Image Gallery: Flagellate dermatitis.
    Br J Dermatol. 2016;174:e23.
    PubMed     Text format    


  42. PARISER DM, Eichenfield LF, Bukhalo M, Waterman G, et al
    Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
    Br J Dermatol. 2016;174:770-7.
    PubMed     Text format     Abstract available


  43. MAURER M, Staubach P, Raap U, Richter-Huhn G, et al
    ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice.
    Br J Dermatol. 2016;174:892-4.
    PubMed     Text format    


    March 2016
  44. TOTTE JE, van der Feltz WT, Hennekam M, van Belkum A, et al
    Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2016 Mar 19. doi: 10.1111/bjd.14566.
    PubMed     Text format     Abstract available


  45. CHON SY, Hassler AA
    Demodex inflammatory eruption due to epidermal growth factor receptor inhibitor therapy.
    Br J Dermatol. 2016;174:686-7.
    PubMed     Text format    


  46. BELLON T, Lerma V, Gonzalez-Valle O, Gonzalez Herrada C, et al
    Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds.
    Br J Dermatol. 2016;174:621-4.
    PubMed     Text format     Abstract available


  47. KURATA M, Horie C, Kano Y, Shiohara T, et al
    Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2016;174:681-3.
    PubMed     Text format    


  48. BENNETT MF, Lowney AC, Bourke JF
    A study of occupational contact dermatitis in the pharmaceutical industry.
    Br J Dermatol. 2016;174:654-6.
    PubMed     Text format    


  49. DAUNTON A, Bridgett C, Goulding JM
    Habit reversal for refractory atopic dermatitis: a review.
    Br J Dermatol. 2016;174:657-9.
    PubMed     Text format    


    February 2016
  50. SHI VY, Foolad N, Ornelas JN, Hassoun L, et al
    Comparing the Effect of Bleach and Water Baths on Skin Barrier Function in Atopic Dermatitis: A Split-Body Randomized Controlled Trial.
    Br J Dermatol. 2016 Feb 15. doi: 10.1111/bjd.14483.
    PubMed     Text format     Abstract available


  51. LEROY V, Lazaro E, Darrigade AS, Taieb A, et al
    Successful rapid subcutaneous desensitization to Anakinra in a case of delayed-type hypersensitivity reaction.
    Br J Dermatol. 2016 Feb 6. doi: 10.1111/bjd.14454.
    PubMed     Text format     Abstract available


  52. HASHIMOTO T, Ohzono A, Ishii N
    'Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus': reply from the authors.
    Br J Dermatol. 2016;174:461-2.
    PubMed     Text format    


  53. AMBER KT
    Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.
    Br J Dermatol. 2016;174:461.
    PubMed     Text format    


  54. BROWN SJ
    Hand dermatitis in construction workers: a lesson in genetic epidemiology.
    Br J Dermatol. 2016;174:263-5.
    PubMed     Text format    


  55. HAUKSSON I, Ponten A, Gruvberger B, Isaksson M, et al
    Skincare products containing low concentrations of formaldehyde detected by the chromotropic acid method cannot be safely used in formaldehyde-allergic patients.
    Br J Dermatol. 2016;174:371-9.
    PubMed     Text format     Abstract available


  56. TIMMERMAN JG, Heederik D, Spee T, van Rooy FG, et al
    Contact dermatitis in the construction industry: the role of filaggrin loss-of-function mutations.
    Br J Dermatol. 2016;174:348-55.
    PubMed     Text format     Abstract available


  57. NEMOTO O, Furue M, Nakagawa H, Shiramoto M, et al
    The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placeb
    Br J Dermatol. 2016;174:296-304.
    PubMed     Text format     Abstract available


  58. DIEPGEN TL, Ofenloch RF, Bruze M, Bertuccio P, et al
    Prevalence of contact allergy in the general population in different European regions.
    Br J Dermatol. 2016;174:319-29.
    PubMed     Text format     Abstract available


  59. STINGENI L, Bianchi L, Tramontana M, Moretta I, et al
    Indoor dermatitis due to Aeroglyphus robustus.
    Br J Dermatol. 2016;174:454-6.
    PubMed     Text format    


  60. SCHLIPF NA, Vahlquist A, Teigen N, Virtanen M, et al
    Whole-exome sequencing identifies novel autosomal recessive DSG1 mutations associated with mild SAM syndrome.
    Br J Dermatol. 2016;174:444-8.
    PubMed     Text format    


    January 2016
  61. HAJDARBEGOVIC E, Blom H, Verkouteren JA, Hofman A, et al
    Atopic dermatitis is not associated with actinic keratosis: cross-sectional results from the Rotterdam study.
    Br J Dermatol. 2016 Jan 29. doi: 10.1111/bjd.14423.
    PubMed     Text format     Abstract available


  62. VAN DER SCHAFT J, Politiek K, van den Reek JM, Kievit W, et al
    Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis.
    Br J Dermatol. 2016 Jan 19. doi: 10.1111/bjd.14398.
    PubMed     Text format     Abstract available


  63. KOCK M, Coenraads PJ, Blomeke B, Goebel C, et al
    Continuous usage of a hair dye product containing 2-methoxymethyl-p-phenylenediamine by hair dye allergic individuals.
    Br J Dermatol. 2016 Jan 8. doi: 10.1111/bjd.14390.
    PubMed     Text format     Abstract available


  64. EZZEDINE K, Barbarot S
    Atopic dermatitis and type-1 diabetes mellitus: a true positive association?
    Br J Dermatol. 2016;174:16.
    PubMed     Text format    


  65. LIN CH, Wei CC, Lin CL, Lin WC, et al
    Childhood type 1 diabetes may increase the risk of atopic dermatitis.
    Br J Dermatol. 2016;174:88-94.
    PubMed     Text format     Abstract available


  66. TSUTSUMI M, Kitahata H, Fukuda M, Kumamoto J, et al
    Numerical and comparative three-dimensional structural analysis of peripheral nerve fibres in epidermis of patients with atopic dermatitis.
    Br J Dermatol. 2016;174:191-4.
    PubMed     Text format    


  67. POLITIEK K, van der Schaft J, Coenraads PJ, de Bruin-Weller MS, et al
    Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis.
    Br J Dermatol. 2016;174:201-3.
    PubMed     Text format    


    December 2015
  68. DRUCKER AM, Li WQ, Lin L, Cho E, et al
    Atopic dermatitis (eczema) in US female nurses: lifestyle risk factors and atopic co-morbidities.
    Br J Dermatol. 2015 Dec 26. doi: 10.1111/bjd.14373.
    PubMed     Text format     Abstract available


  69. UTER W
    Fragrance contact allergy in the population.
    Br J Dermatol. 2015;173:1358-9.
    PubMed     Text format    


    November 2015
  70. VINTER H, Kragballe K, Steiniche T, Gaestel M, et al
    TNFalpha plays a significant role in the Aldara-induced skin inflammation in mice.
    Br J Dermatol. 2015 Nov 28. doi: 10.1111/bjd.14320.
    PubMed     Text format     Abstract available


  71. OFENLOCH R, Diepgen TL, Bruze M, Cazzaniga S, et al
    Colophony as marker for fragrance allergy in the general European population.
    Br J Dermatol. 2015 Nov 19. doi: 10.1111/bjd.14297.
    PubMed     Text format     Abstract available


  72. LI K, Seok J, Park KY, Yoon Y, et al
    Copy-number variation of the Filaggrin in Korean patients with atopic dermatitis: what really matters - "number" or "variation"?
    Br J Dermatol. 2015 Nov 11. doi: 10.1111/bjd.14287.
    PubMed     Text format     Abstract available


  73. ANAGNOSTOU K, Clark A
    Author response to Marrs et al., Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal.
    Br J Dermatol. 2015;173:1129-30.
    PubMed     Text format    


  74. MARRS T, Flohr C, Perkin MR
    Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal.
    Br J Dermatol. 2015;173:1125-9.
    PubMed     Text format     Abstract available


  75. APFELBACHER C
    Onset and severity of atopic dermatitis, atopy and hand eczema in adolescents.
    Br J Dermatol. 2015;173:1121-2.
    PubMed     Text format    


    September 2015
  76. CARRASCOSA R, Llamas-Velasco M, Montes-Torres A, Sanchez-Perez J, et al
    Does boceprevir really increase the risk of skin eruptions during antihepatitis C treatment?
    Br J Dermatol. 2015 Sep 15. doi: 10.1111/bjd.14169.
    PubMed     Text format     Abstract available


    July 2015
  77. WU J, Lee YY, Su SC, Wu TS, et al
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in patients with malignancies.
    Br J Dermatol. 2015 Jul 27. doi: 10.1111/bjd.14052.
    PubMed     Text format     Abstract available


  78. NIANG SO, Tine Y, Diatta BA, Diallo M, et al
    Negative cutaneous effects of medicinal plants in Senegal.
    Br J Dermatol. 2015;173 Suppl 2:26-29.
    PubMed     Text format     Abstract available


  79. GRUBER R
    Increased risk of psoriasis in individuals with childhood asthma: therapeutic implications?
    Br J Dermatol. 2015;173:14.
    PubMed     Text format    


    June 2015
  80. MALERBA M, Damiani G, Radaeli A, Ragnoli B, et al
    Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma.
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13988.
    PubMed     Text format     Abstract available


  81. PIRMEZ R, Fernandes AL, Melo MG
    Photoaggravated contact dermatitis to Kathon CG (methylchloroisothiazolinone/methylisothiazolinone): a novel pattern of involvement in a growing epidemic?
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13986.
    PubMed     Text format     Abstract available


  82. SINHA R, Larkin J, Gore M, Fearfield L, et al
    Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF mutation-positive metastatic melanoma, including recognition and management of rare presentations.
    Br J Dermatol. 2015 Jun 24. doi: 10.1111/bjd.13958.
    PubMed     Text format     Abstract available


  83. BALLARDINI N
    The association between psoriasis and asthma.
    Br J Dermatol. 2015;172:1485-6.
    PubMed     Text format    


  84. SILVERBERG JI
    Long-term use of ciclosporin in a real-world setting.
    Br J Dermatol. 2015;172:1483-4.
    PubMed     Text format    


  85. BANDIER J, Carlsen BC, Rasmussen MA, Petersen LJ, et al
    Skin reaction and regeneration after single sodium lauryl sulfate exposure stratified by filaggrin genotype and atopic dermatitis phenotype.
    Br J Dermatol. 2015;172:1519-29.
    PubMed     Text format     Abstract available


  86. LONNBERG AS, Skov L, Skytthe A, Kyvik KO, et al
    Asthma in patients with psoriasis.
    Br J Dermatol. 2015;172:1660-1.
    PubMed     Text format    


    May 2015
  87. HOEGER PH
    Prognostic parameters in Henoch-Schonlein purpura.
    Br J Dermatol. 2015;172:1191-2.
    PubMed     Text format    


  88. VADASZ Z, Toubi E
    The role of increased T helper cell 2 cytokine expression in skin weals of chronic spontaneous urticaria: are they always activating cytokines?
    Br J Dermatol. 2015;172:1185-6.
    PubMed     Text format    


  89. SCHMITT J
    Trials are meaningful for clinical decision making only when their endpoints are valid and comparable.
    Br J Dermatol. 2015;172:1175-7.
    PubMed     Text format    


    April 2015
  90. DE KONING HD, van Vlijmen-Willems IM, Rodijk-Olthuis D, van der Meer JW, et al
    Mast cell interleukin-1 beta, neutrophil interleukin-17 and epidermal antimicrobial proteins in the neutrophilic urticarial dermatosis in Schnitzler's syndrome.
    Br J Dermatol. 2015 Apr 22. doi: 10.1111/bjd.13857.
    PubMed     Text format     Abstract available


    March 2015
  91. EGEBERG A, Khalid U, Gislason GH, Mallbris L, et al
    Risk of psoriasis in patients with childhood asthma - a Danish nationwide cohort study.
    Br J Dermatol. 2015 Mar 20. doi: 10.1111/bjd.13781.
    PubMed     Text format     Abstract available


  92. ALLOO A, Sheu J, Butrynski JE, DeAngelo DJ, et al
    Ponatinib-Induced Pityriasiform, Folliculocentric and Ichthyosiform Cutaneous Toxicities.
    Br J Dermatol. 2015 Mar 4. doi: 10.1111/bjd.13692.
    PubMed     Text format     Abstract available


  93. CHENG L, Xiong Y, Qin CZ, Zhang W, et al
    HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.
    Br J Dermatol. 2015 Mar 2. doi: 10.1111/bjd.13688.
    PubMed     Text format    


  94. HARDIN J, Haber RM
    Onychomadesis: literature review.
    Br J Dermatol. 2015;172:592-6.
    PubMed     Text format     Abstract available


  95. LEW TT, Creamer D, Mackenzie J, Walsh SA, et al
    Post-traumatic stress disorder following drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2015;172:836-7.
    PubMed     Text format    


  96. RAOOF N, Salvi SM
    Self-injection of dermal filler: an underdiagnosed entity?
    Br J Dermatol. 2015;172:782-3.
    PubMed     Text format     Abstract available


    February 2015
  97. MROWIETZ U
    Aldara-induced skin inflammation in mice: close enough to psoriasis?
    Br J Dermatol. 2015;172:313.
    PubMed     Text format    


  98. VERCUEIL A, Walsh S
    Extracutaneous manifestations and long-term sequelae of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Br J Dermatol. 2015;172:312.
    PubMed     Text format    


  99. SMULDERS S, Golanski L, Smolders E, Vanoirbeek J, et al
    Nano-TiO2 modulates the dermal sensitization potency of dinitrochlorobenzene after topical exposure.
    Br J Dermatol. 2015;172:392-9.
    PubMed     Text format     Abstract available


    January 2015
  100. MIYAKE T, Yamamoto T, Hirai Y, Otsuka M, et al
    Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
    Br J Dermatol. 2015;172:56-63.
    PubMed     Text format     Abstract available


  101. POT LM, Coenraads PJ, Goebel C, Blomeke B, et al
    Assessment of the elicitation response in subjects weakly sensitized to p-phenylenediamine.
    Br J Dermatol. 2015;172:138-44.
    PubMed     Text format     Abstract available


  102. POLIGONE B
    Risk of mortality in hydroa vacciniforme and hypersensitivity to mosquito bites.
    Br J Dermatol. 2015;172:5-6.
    PubMed     Text format    


    December 2014
  103. DUONG TA, de Prost N, Ingen-Housz-Oro S, Carrie AS, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission.
    Br J Dermatol. 2014 Dec 11. doi: 10.1111/bjd.13505.
    PubMed     Text format     Abstract available


    November 2014
  104. FANG HY, Liao WC, Lin CL, Chen CH, et al
    Association Between Psoriasis and Asthma: A Population-Based Retrospective Cohort Analysis.
    Br J Dermatol. 2014 Nov 10. doi: 10.1111/bjd.13518.
    PubMed     Text format     Abstract available


    July 2014
  105. VINTER H, Iversen L, Steiniche T, Kragballe K, et al
    Aldara-induced skin inflammation - studies of psoriasis patients.
    Br J Dermatol. 2014 Jul 1. doi: 10.1111/bjd.13236.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: